期刊文献+

B型钠尿肽在右心衰竭诊断和治疗中的作用 被引量:2

Effect of B-type natriuretic peptide in diagnosis and therapy of right heart failure
原文传递
导出
摘要 近年来研究发现,在各种原因引起的右心压力和容积超负荷中,B型钠尿肽与肺动脉压、右心室压、右心室舒张末期容积及右心射血分数等存在明显的关系,表明B型钠尿肽可能在右心功能不全及右心衰竭中起到诊断作用,并可能用于判断治疗效果和预后的指导。由于B型钠尿肽具有舒张血管及抗心肌肥大等效应,重组B型钠尿肽或神经内肽酶阻滞剂治疗右心室功能障碍和肺动脉高压具有较好的前景。该文通过阐述B型钠尿肽的特性及其在造成右心损伤的不同病理过程中的变化趋势,了解其在右心衰竭中潜在的诊断和治疗上的作用。
出处 《国际儿科学杂志》 2008年第6期545-548,共4页 International Journal of Pediatrics
基金 河南省卫生厅医学科技攻关基金资助项目(200716602)
  • 相关文献

参考文献35

  • 1Yap LB, Mukerjee D, Timms PM, et al. Natriuretic peptides, respiratory disease, and the right heart. Chest,2004,126(4):1330-1336.
  • 2Catdiez B, Berthe MC, Lavoinne A. Brain natriuretic peptide: physiological, biological and clinical aspects. Ann Biol Clin(Paris) ,2005,63(1 ) : 15-25.
  • 3Klinger JR, Warburton RR, Pietras LA, et al. Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia induced cardiac hypertrophy. Am J Physiol Heart Grc Physiol, 2002,252 ( 1 ) : 58-65.
  • 4Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coil Cardiol, 1998,31 ( 1 ) : 202-208.
  • 5Usui S,Yao A,Hatano M,et al.Upregulated neurohumoral factors are associated with left ventrieular remodeling and poor prognosis in rats with monoerotaline-inducod pulmonary arterial hypertension. Circ J, 2006, 70 (9) : 1208-1215.
  • 6Kruger S,Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J, 2004,147 ( 1 ) : 60-65.
  • 7Tulevski II, ten Wolde M, van Veldhuisen DJ, et al. Combined utility of brain rtatriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol,2007,116(2) : 161-166.
  • 8Bal L, Thierry S, Brocas E, et al. B-type natriuretic peptide (BNP) and Ntenninal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Acta Anaesthesiol Stand, 2006,50(3) : 340-347.
  • 9Suda K,Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int, 2003,45 (3) :249-254.
  • 10邢云利 贾三庆.BNP可作为心衰诊断和预后的新指标[J].中国医学论坛报,2002,28:14-14.

二级参考文献16

  • 1吴振西,尹欣,王联发,陈训.心力衰竭患者脑钠素与心功能相关性研究[J].中华心血管病杂志,2005,33(3):296-296. 被引量:25
  • 2邢云利 贾三庆.BNP可作为心衰诊断和预后的新指标[J].中国医学论坛报,2002,28:14-14.
  • 3全国肺心病协作组.慢性肺源性心脏病诊断标准[J].中华结核和呼吸系疾病杂志,1978,20(1):56-57.
  • 4胡亚美 江载芳 陆华 申昆玲 左启华 李同 等.实用儿科学(第7版)[M].北京:人民卫生出版社,2002.698-705.
  • 5Bettencourt P, Ferreira A , Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology,2000;93(1-2) : 19.
  • 6Koglin J, Pehlivanli S ,Schwaiblmair M, et al . Role of brain natriuretie peptide in risk stratification of patients with congestive heart failure . J Am Coll Cardiol ,2001;38(7) : 1934.
  • 7Peter A, Mc-Cullough MD, Maisel MD ,et al . Btype natriuretic peptides: a diagnostic breakthough for clinicians . Reviews in Cardiovascular Medicine, 2003;4(2) : 72.
  • 8Kunii Y, Kamada M, Ohtsuki S, et al . Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama ,2003;57(4) : 191.
  • 9Koch A , Singer H . Normal valure of B type natriuretic peptide in infants , children , and adolescents. Heart,2003;89(8) : 875.
  • 10Puddy VF, Amirmansour C, Williams AP, et at .Plasma brain natriuretic peptide as a predictor of haemodynamically significant p:tent ductus arteriosus in preterm infants, Clin Sci (Lond), 2002;103 (1) : 75.

共引文献6

同被引文献16

  • 1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:117
  • 2陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
  • 3逄坤静,王浩.超声心动图定量测量先天性心脏病肺动脉高压全肺阻力的方法学研究[J].中国超声医学杂志,2007,23(5):394-396. 被引量:12
  • 4中华医学会心血管病学分会,中华心血管病杂志编辑委员会.右心衰竭诊断和治疗中国专家共识[J].中华血管病杂志,2012,6(40):449-461.
  • 5Haddad F, Ashley E,Michelakis ED.New insights for the diagnosis and management of right ventricular failure, from Molecular imaging to targeted right ventricular therapy C J/ ~ Curt Opin Cardio,2010,25(2): 131-140.
  • 6Hawkins NM,Petrie MC, Jhund PS,et al.Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology [J] .Eur J Heart Fail,2009,11(2):130-139.
  • 7Rudski LG,Lai WW, Afilalo J,et al.Guidelines for the echo cardio-graphic assessment of the right heart in adults:a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography [J] .J Am Soc Echocardiogr, 2010,23(7):685-713.
  • 8Rauch H,Motsch J,B6ttiger BW.Newer approaches to the pharmacological management of heart failure[J] .Curt Opin Anaesthesiol,2006,19 ( 1 ):75- 81.
  • 9Harmink JD,van Helvoort HA,Dekhuijzen PN,et al.Heartfailure and COPD:partners in crime [J] .Respirology,2010, 15(6):890-901.
  • 10Rajagopalan N,Simon MA,Mathier MA,et al.Identifying right Ventricular dysfunctionwith tissue Doppler imaging in pulmonary hypertension [J] .Int J Cordiol,2008,128(3):359-363.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部